Singapore's health ministry. Since 1 September 2022 it decides, through its Cancer Drug List, which outpatient cancer treatments MediShield Life and MediSave will pay for and up to what monthly limit.
The Ministry of Health sets the rules for Singapore's health financing schemes. Its own pages describe MediShield Life as a basic health insurance scheme for all Singapore citizens and permanent residents, administered by the Central Provident Fund Board, and MediSave as a national medical savings scheme. In August 2021 it announced changes to the financing of outpatient cancer treatment, and from 1 September 2022 MediShield Life and MediSave cover only treatments on its Cancer Drug List, each with its own monthly claim limit. Its FAQs say the list comprises treatments that are clinically proven (registered by the Health Sciences Authority for the indication) and more cost-effective, that companies make the case through a submission to the Agency for Care Effectiveness, and that the list is updated three times a year. The coordinates on this record are an approximate city point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/